RE:RE:RE:RE:News Release - Horrible as ExpectedJust remain to hold. Analysts have a strong buy on this stock still. Tons of insider buys at 26 plus cents. They know something is going to happen. For the price of this stock you cannot buy anything cheaper with a strong business model. Triple triple will come for the patient. I just bought last week. I always make thirty five percent within three months.